Table 2.
Progression of Precancerous Cervical Lesion Associated with p16 IHC Staining
| Total (%) | Progressive/recurrent CIN2+ (%) | ||
|---|---|---|---|
| LSIL | Negative p16 IHC | 84 (77.7) | 3 (3.6) |
| (N = 108) | Positive p16 IHC | 24 (22.2) | 4 (16.7) |
| HSIL | Negative p16 IHC | 12 (15.2) | 1 (8.3) |
| (N = 79) | Positive p16 IHC | 67 (84.8) | 12 (17.9) |
CIN2+, cervical intraepithelial neoplasia 2 or worse; p16 IHC, p16 protein-immunohistochemistry staining